Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis
Sponsor: University of Alabama at Birmingham
Summary
The purpose of this pilot study is to explore wither ivacaftor in refractory CRS patients will demonstrate safety and tolerability; restore CFTR-mediated Cl- secretions as measured by EDSPD testing; produce detectable improvements in validated measures of CRS including the SNOT-22 questionnaire, Lund-MacKay CT scan grading, and Lund-Kennedy endoscopic scores; and provide beneficial effects on readily measured markers of sinonasal inflammation and infection (IP-10, IL-8, and Pseudomonas CFUs).
Official title: Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis (Randomized Pilot Study Utilizing Ivacaftor for the Treatment of Refractory Gram-Negative Bacterial CRS)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2019-05-02
Completion Date
2026-04
Last Updated
2025-04-16
Healthy Volunteers
No
Conditions
Interventions
Ivacaftor
150 mg tablet PO BID x 14 days
standard of care treatment
topical nasal steroid spray and culture-directed antibiotics x 14 days
Locations (1)
University of Alabama at Birmingham
Birmingham, Alabama, United States